← IndicationsOpen filtered programs
Landscape
Sudden Hearing Loss
Sudden Hearing Loss has 12 tracked records across 4 named organizations, including 0 strong-evidence records and 5 active programs. Records with caveats and trial-derived candidates remain visible for deeper review.
12
Pipeline Records
strong evidence + caveats + candidates
0
Strong Evidence
12 checked records with caveats
5
Active Programs
currently active
0
Marketed / Approved
commercial or approved
4
Organizations
companies, sponsors, and institutions
Competitive Density
16/100
organization breadth + program volume
Pipeline Velocity
34/100
active and late-stage share
Evidence Coverage
0/100
share strong evidence
Completion Signal
17/100
late-stage, approved, or marketed
Attrition Rate
0/100
share discontinued
Concentration
67/100
top-organization share
Programs by Stage
Early Phase 11 · 8%
Phase 12 · 17%
Phase 22 · 17%
Phase 32 · 17%
Not applicable5 · 42%
Trial / Program Status
Active5 · 42%
Completed1 · 8%
Paused1 · 8%
Unknown5 · 42%
Modality Breakdown
Small Molecule3 · 25%
Steroid/Anti-inflammatory3 · 25%
Procedural Anesthesia/Pain-Control Study2 · 17%
Cell Therapy1 · 8%
Combination Drug/Procedure Study1 · 8%
Nerve Block/Medication Combination Study1 · 8%
Regenerative Medicine1 · 8%
Program Types
Therapeutic8 · 67%
Procedure/Rehab4 · 33%
Top Organizations
Institution-led study8 · 67%
Investigator-led study2 · 17%
Phafag AG1 · 8%
Truway Health, Inc.1 · 8%
Population Tags
adult12 · 100%
sudden-hearing-loss6 · 50%
sensorineural5 · 42%
sudden5 · 42%
tinnitus3 · 25%
autologous1 · 8%
cell-derived-vesicles1 · 8%
combination-study1 · 8%
extracellular-vesicles1 · 8%
inner-ear-disease1 · 8%
Strong-Evidence Programs
0 recordsNo strong-evidence records yet for this indication.
Checked Records With Caveats
12 recordsIntratympanic injection anesthesia-method comparison studyStatus caveat
Sponsor / Institution: Institution-led study · Not applicable · Completed
Procedural Anesthesia/Pain-Control StudyNot applicableCompleted87% confidence
Intratympanic dexamethasone versus methylprednisolone sudden-hearing-loss studyStatus caveat
Sponsor / Institution: Institution-led study · Not applicable · Unknown
Steroid/Anti-inflammatoryNot applicableUnknown84% confidence
Tetracaine versus phenol intratympanic anesthesia studyStatus caveat
Sponsor / Institution: Institution-led study · Early Phase 1 · Unknown
Procedural Anesthesia/Pain-Control StudyEarly Phase 1Unknown84% confidence
Oral versus intratympanic glucocorticoid ISSNHL vestibular prognosis studyStatus caveat
Sponsor / Institution: Institution-led study · Not applicable · Unknown
Steroid/Anti-inflammatoryNot applicableUnknown84% confidence
Prednisone plus stimulation sudden-deafness studyStatus caveat
Sponsor / Institution: Investigator-led study · Not applicable · Unknown
Combination Drug/Procedure StudyNot applicableUnknown83% confidence
Sudden-deafness nerve-block plus mecobalamin studyStatus caveat
Sponsor / Institution: Investigator-led study · Not applicable · Unknown
Nerve Block/Medication Combination StudyNot applicableUnknown83% confidence
AP-HP SERORL aspirin and folic acid SSNHL studyStatus caveat
Sponsor / Institution: Institution-led study · Phase 3 · Active
Small MoleculePhase 3Active82% confidence
Fudan intracochlear glucocorticoid SSNHL studyStatus caveat
Sponsor / Institution: Institution-led study · Phase 2 · Active
Steroid/Anti-inflammatoryPhase 2Active82% confidence
Transtympanic caroverine by PhafagStatus caveat
Company: Phafag AG · Phase 3 · Paused
Small MoleculePhase 3Paused80% confidence
Chang Gung hydroxychloroquine adjunct SSNHL studyStatus caveat
Sponsor / Institution: Institution-led study · Phase 2 · Active
Small MoleculePhase 2Active80% confidence
Sun Yat-sen autologous monocyte vesicles sudden deafness studyStatus caveat
Sponsor / Institution: Institution-led study · Phase 1 · Active
Cell TherapyPhase 1Active80% confidence
Truway Health HEAR-RESTORE exploratory inner-ear regenerative studyStatus caveat
Company: Truway Health, Inc. · Phase 1 · Active
Regenerative MedicinePhase 1Active68% confidence